ABB-N 0 ROK-N 5.41 SIEGY-OTC 0 NVDA-Q 3.82 BAC-N 0.43 MSCI-N -5.07 GRBK-Q 0.23
Daily Stock Opinions and Ratings
The ultimate 360° Tracker Your financial life in one place, automatically
Stockchase Opinions

Robert Floyd PanGeo Pharma PIL.H-X DON'T BUY Jul 04, 2003

Auditors left and have to be replaced and trading has been stopped until their reports are in.
Robert FloydRobert Floyd
Owned
Unlock Rating
$0.290

Stock price when the opinion was issued

biotechnology pharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
Get Signals Create your Watchlist

You might be interested:

BUY

PanGeo Pharma(PIL.H-X)

Mar 27, 2003
Earnings warnings were forcast. Seems to be corrected now. Cheap.
Robert FloydRobert Floyd
Unknown
Unlock Rating
$0.730

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

PanGeo Pharma(PIL.H-X)

Mar 31, 2003
Likes this sector, but they just gave a lower guidance.
John Sinkins, CFAJohn Sinkins, CFA
Unknown
Unlock Rating
$0.690

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

PanGeo Pharma(PIL.H-X)

Apr 10, 2003
Has warned a few times. Making some strategic moves in beefing up their management. A reasonable bet.
Robert FloydRobert Floyd
Unknown
Unlock Rating
$0.770

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

PanGeo Pharma(PIL.H-X)

Apr 25, 2003
Made a good move in splitting the offices of the chairman and the CEO. They are trying to deal with their problems. Have to see an improvement before there is any interest.
Robert FloydRobert Floyd
Unknown
Unlock Rating
$0.760

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

PanGeo Pharma(PIL.H-X)

May 06, 2003
Have had some pretty big earnings misses and management issues. May be a take over target at some point. Wait for it to drop further.
Peter HodsonPeter Hodson
Unknown
Unlock Rating
$0.960

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

PanGeo Pharma(PIL.H-X)

May 30, 2003
Very extended. Squeezing their credit lines and suppliers. Have to earn $0.10 a share to support the liquidity issue.
Lou SchizasLou Schizas
Unknown
Unlock Rating
$0.740

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

PanGeo Pharma(PIL.H-X)

Jul 02, 2003
In a very defined downtrend.
Bill CarriganBill Carrigan
No
Unlock Rating
$0.290

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

PanGeo Pharma(PIL.H-X)

Jul 22, 2003
Doesn't look good.
David BurrowsDavid Burrows
No
Unlock Rating
$0.290

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

PanGeo Pharma(PIL.H-X)

Sep 22, 2003
Trading has been stopped. Plagued by a number of problems. Waiting for the company to complete its audit.
Robert FloydRobert Floyd
Owned
Unlock Rating
$0.290

Stock price when the opinion was issued

biotechnology pharmaceutical

Your Watchlist

Add stocks to watchlist to monitor them daily and get important alerts.

Latest Buy Signals

ANET-N 2.09$70.76
GS-N 9.32$529.31
PAYC-N 7.71$219.23
VRT-N 6.18$78
GEV-N 10.02$336.09

Today's Top Picks

ABB-N 0$50.68
ROK-N 5.41$239.83
SIEGY-… 0$109.48
NVDA-Q 3.82$102.71
BAC-N 0.43$38.75

Popular Articles

Questrade Review: Pros & Cons of Trading with Questrade Canada (2021) Steady Eddys: 3 Stable Stocks Between Safety and Risk: 3 Safe and Gambling Stocks 3 Oversold Stocks to Take Advantage of 5 ETFs for Index Investing

Latest Sell Signals

CAT-N 4.6$295.77
BCE-T 0.07$30.84
KHC-Q -0.11$30.09
ECN-T 0.09$2.84
DHI-N -0.17$124.79

Most Recent Experts

Kim Bolton

Black Swan Dexteritas

Jim Cramer - Mad Money

CNBC

Paul Harris, CFA

Harris Douglas Asset Management

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

© Stockchase Inc.